Cardiac protective mechanisms of melanocortin system activation
黑皮质素系统激活的心脏保护机制
基本信息
- 批准号:10585732
- 负责人:
- 金额:$ 58.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-01-09 至 2026-12-31
- 项目状态:未结题
- 来源:
- 关键词:AgonistAmericanAnimal ModelAnimalsAnterior Descending Coronary ArteryAortaAreaBackBiogenesisBloodBlood - brain barrier anatomyBrainBrain StemBypassCardiacCardiac MyocytesCardiac OutputCardiovascular DiseasesCardiovascular systemCell NucleusCentral Nervous SystemCerebral VentriclesChronicCongestive Heart FailureDataDiameterDisease ProgressionDoseEFRACEchocardiographyEnergy MetabolismGeneticGenetic EngineeringGlucoseHealthcareHeartHeart failureHumanHypothalamic structureImaging TechniquesImaging technologyIn VitroInfusion proceduresKnock-outLateralLeftLeft atrial structureLeft ventricular structureLeptinLeptin resistanceLigationMeasurementMeasuresMediatingMelanocortin 4 ReceptorMetabolicMetabolic stressMitochondriaMolecularMorbidity - disease rateMorphologyMusMuscle functionMuscle strainMyocardial InfarctionMyocardial dysfunctionMyocardiumObesityOutcome StudyPathway interactionsPatientsPeripheralPreparationProductionProtocols documentationRattusReceptor ActivationResistanceResolutionRiskRisk FactorsSirtuinsSystemTestingThinnessUnited Statesblood-brain barrier crossingcardioprotectioncare burdencholinergic neurondorsal motor nucleuseffective therapyexercise capacityfatty acid oxidationheart functionheart preservationimprovedin vivoinnovationmelanotan-IImortalitynovelnovel therapeutic interventionobese patientsobesity geneticsoxidationparaventricular nucleuspreventprotective effectsuccesstherapeutically effectiveultrasound
项目摘要
PROJECT SUMMARY/ABSTRACT
Over 1.5 million Americans suffer from myocardial infarction (MI) each year, and about 25% of these patients
develop severe cardiac dysfunction including congestive heart failure (HF), which has a high 5-year mortality
rate of ~50%. Current therapies following MI have limited success in attenuating cardiac dysfunction and slowing
HF progression. Thus, there is a critical need for novel, more effective therapies that protect the heart, improve
its function, and slow/halt progression of cardiac dysfunction. We recently demonstrated that activation of the
brain leptin-melanocortin system pathway greatly improves cardiomyocyte energy metabolism and contractility,
preserves cardiac function, and prevents progression of HF following MI induced by ligation of the left anterior
descending coronary artery. We observed that intracerebroventricular (ICV) infusion of leptin for 4 weeks, at a
low dose that did not alter blood leptin concentration, restored ejection fraction, cardiac output, left ventricle (LV)
muscle strain and left atrium/aorta diameter ratio almost all the way back to normal baseline values, and
preliminary data suggest that other measures of cardiac function such as +dP/dtmax and exercise capacity were
also markedly improved. We also observed that these cardiac protective effects are absent in melanocortin 4
receptor (MC4R) deficient rats and that activation of brain MC4R using synthetic agonists infused into the
cerebral ventricles protected the heart against progressive cardiac dysfunction after MI in a similar fashion
compared to leptin treatment. Our preliminary data also indicate that activation of the CNS leptin-MC4R pathway
increases sirtuin-3 (SIRT3) expression, mitochondrial biogenesis and substrate oxidation (i.e., glucose and fatty
acid oxidation), and improves cardiomyocyte contractility in non-infarcted regions of the LV, including areas at
risk but still viable. The central hypothesis of this proposal is that activation of the brain melanocortin system
improves cardiac function and prevents progression of HF after MI, increases myocardium
mitochondrial biogenesis and SIRT3 levels, enhances substrate oxidation, and improves energy
production and cardiomyocyte contractility in healthy portions of the heart. We also propose that these
beneficial effects of the melanocortin system on the heart require MC4R activation in PVN and/or
DMV/NTS/IML, and that MC4R agonists that cross the blood-brain barrier (e.g. setmelanotide) and can
be administered systemically will be effective to provide cardioprotective even in the setting of obesity.
We will use state-of-the-art chronic in vivo protocols with high-resolution ultrasound techniques for imaging
cardiac function (including 4D-strain echocardiographic imaging technology) in genetically engineered animal
models combined with ex vivo and in vitro preparations for detailed measurements of cardiac muscle function,
morphology, energy metabolism and contractility to test our hypotheses. The outcomes from this study could
lead to novel and more effective therapeutic approaches for MI and HF, and will provide a new target for MC4R
agonists which are currently being used to treat rare forms of genetic obesity in humans.
项目总结/摘要
每年有超过150万美国人患有心肌梗死(MI),其中约25%的患者
发生严重的心功能不全,包括充血性心力衰竭(HF),5年死亡率较高
率~ 50%。目前MI后的治疗在减轻心功能不全和减缓心功能不全方面的成功有限。
HF进展。因此,迫切需要新的、更有效的治疗方法,其保护心脏,改善心功能,
其功能和减缓/停止心功能障碍进展。我们最近证明,
脑瘦素-黑皮质素系统途径大大改善心肌细胞能量代谢和收缩力,
保护心脏功能,并防止左前叶结扎诱导的MI后HF的进展
冠状动脉降支。我们观察到脑室(ICV)输注瘦素4周,
低剂量不改变血液瘦素浓度,恢复射血分数,心输出量,左心室(LV)
肌肉拉伤和左心房/主动脉直径比几乎完全恢复到正常基线值,以及
初步数据表明,心脏功能的其他指标,如+dP/dtmax和运动能力,
也有明显改善。我们还观察到这些心脏保护作用在黑皮质素4中不存在,
受体(MC 4 R)缺陷大鼠和脑MC 4 R的激活使用合成激动剂注入到
脑室以类似的方式保护心脏免受MI后进行性心功能不全的影响
与瘦素治疗相比。我们的初步数据还表明,中枢神经系统瘦素-MC 4 R通路的激活,
增加沉默调节蛋白-3(SIRT 3)表达,线粒体生物发生和底物氧化(即,葡萄糖和脂肪
酸氧化),并改善LV非梗死区域的心肌细胞收缩性,包括
风险,但仍然可行。这个提议的中心假设是大脑黑皮质素系统的激活
改善心脏功能,预防MI后HF进展,增加心肌
线粒体生物合成和SIRT 3水平,增强底物氧化,并提高能量
在心脏的健康部分中的生产和心肌细胞收缩性。我们还建议,
黑皮质素系统对心脏的有益作用需要PVN中的MC 4 R活化和/或
DMV/NTS/IML,以及MC 4 R激动剂,其穿过血脑屏障(例如,塞替米拉诺肽)并且可以
即使在肥胖的情况下,全身给药也能有效地提供心脏保护。
我们将使用最先进的慢性体内协议与高分辨率超声成像技术
基因工程动物心脏功能(包括4D应变超声心动图成像技术)
与离体和体外制备物组合的模型用于详细测量心肌功能,
形态、能量代谢和收缩性来检验我们的假设。这项研究的结果可以
为心肌梗死和心力衰竭的治疗提供了新的、更有效的方法,并将为MC 4 R提供新的靶点
目前用于治疗人类中罕见形式的遗传性肥胖症的激动剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alexandre Alves da Silva其他文献
High-fat diets are detrimental of the lipid profile, glucose metabolism and body composition of Wistar rats: the role of fatty acid type and consumption duration
高脂肪饮食对 Wistar 大鼠的血脂、糖代谢和身体成分有害:脂肪酸类型和食用持续时间的作用
- DOI:
10.1108/nfs-07-2020-0282 - 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
Arthur Rocha;Juliana Dara Silva;Thais Angélica Morais;A. M. R. Ferreira;Viviane Cristina Costa;Amanda Escobar Teixeira;M. R. Lessa;Alexandre Alves da Silva;N. V. Dessimoni;T. R. Riul - 通讯作者:
T. R. Riul
Alexandre Alves da Silva的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Collaborative Research: REU Site: Earth and Planetary Science and Astrophysics REU at the American Museum of Natural History in Collaboration with the City University of New York
合作研究:REU 地点:地球与行星科学和天体物理学 REU 与纽约市立大学合作,位于美国自然历史博物馆
- 批准号:
2348998 - 财政年份:2025
- 资助金额:
$ 58.56万 - 项目类别:
Standard Grant
Collaborative Research: REU Site: Earth and Planetary Science and Astrophysics REU at the American Museum of Natural History in Collaboration with the City University of New York
合作研究:REU 地点:地球与行星科学和天体物理学 REU 与纽约市立大学合作,位于美国自然历史博物馆
- 批准号:
2348999 - 财政年份:2025
- 资助金额:
$ 58.56万 - 项目类别:
Standard Grant
Understanding Latin American Challenges in the 21st Century (LAC-EU)
了解拉丁美洲在 21 世纪面临的挑战 (LAC-EU)
- 批准号:
EP/Y034694/1 - 财政年份:2024
- 资助金额:
$ 58.56万 - 项目类别:
Research Grant
Conference: North American High Order Methods Con (NAHOMCon)
会议:北美高阶方法大会 (NAHOMCon)
- 批准号:
2333724 - 财政年份:2024
- 资助金额:
$ 58.56万 - 项目类别:
Standard Grant
Collaborative Research: RUI: Continental-Scale Study of Jura-Cretaceous Basins and Melanges along the Backbone of the North American Cordillera-A Test of Mesozoic Subduction Models
合作研究:RUI:北美科迪勒拉山脊沿线汝拉-白垩纪盆地和混杂岩的大陆尺度研究——中生代俯冲模型的检验
- 批准号:
2346565 - 财政年份:2024
- 资助金额:
$ 58.56万 - 项目类别:
Standard Grant
REU Site: Research Experiences for American Leadership of Industry with Zero Emissions by 2050 (REALIZE-2050)
REU 网站:2050 年美国零排放工业领先地位的研究经验 (REALIZE-2050)
- 批准号:
2349580 - 财政年份:2024
- 资助金额:
$ 58.56万 - 项目类别:
Standard Grant
Collaborative Research: RUI: Continental-Scale Study of Jura-Cretaceous Basins and Melanges along the Backbone of the North American Cordillera-A Test of Mesozoic Subduction Models
合作研究:RUI:北美科迪勒拉山脊沿线汝拉-白垩纪盆地和混杂岩的大陆尺度研究——中生代俯冲模型的检验
- 批准号:
2346564 - 财政年份:2024
- 资助金额:
$ 58.56万 - 项目类别:
Standard Grant
Conference: Latin American School of Algebraic Geometry
会议:拉丁美洲代数几何学院
- 批准号:
2401164 - 财政年份:2024
- 资助金额:
$ 58.56万 - 项目类别:
Standard Grant
Collaborative Research: Ionospheric Density Response to American Solar Eclipses Using Coordinated Radio Observations with Modeling Support
合作研究:利用协调射电观测和建模支持对美国日食的电离层密度响应
- 批准号:
2412294 - 财政年份:2024
- 资助金额:
$ 58.56万 - 项目类别:
Standard Grant
Conference: Doctoral Consortium at Student Research Workshop at the Annual Conference of the North American Chapter of the Association for Computational Linguistics (NAACL)
会议:计算语言学协会 (NAACL) 北美分会年会学生研究研讨会上的博士联盟
- 批准号:
2415059 - 财政年份:2024
- 资助金额:
$ 58.56万 - 项目类别:
Standard Grant